Results 61 to 70 of about 204,259 (398)
Estimation of Warfarin Dosage with Reinforcement Learning [PDF]
arXiv, 2021 In this paper, it has attempted to use Reinforcement learning to model the proper dosage of Warfarin for patients.The paper first examines two baselines: a fixed model of 35 mg/week dosages and a linear model that relies on patient data. We implemented a LinUCB bandit that improved performance measured on regret and percent incorrect.
arxiv
Three- versus four-factor prothrombin complex concentrate for the reversal of warfarin-induced bleeding [PDF]
, 2018 Objective: The objective of this study was to evaluate the effectiveness of 3-factor prothrombin complex concentrate (3F-PCC) compared to 4-factor PCC (4F-PCC) in warfarin-associated bleeding. Methods: This multicenter, retrospective, cohort study
Abraham, Prasad +6 more
core +1 more source
GRADE Evidence to Decision (EtD) frameworks : a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines [PDF]
, 2016 Funding: Work on this article has been partially funded by the European Commission FP7 Program (grant agreement 258583) as part of the DECIDE project. Sole responsibility lies with the authors; the European Commission is not responsible for any use that ...
the GRADE Working Group
core +1 more source
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range [PDF]
, 2016 BACKGROUND: The benefits and harms of oral anticoagulation (OAC) therapy in patients with only one stroke risk factor (i.e. CHA2DS2-VASc= 1 in males, or 2 in females) has been subject of debate.
Lip, Gregory Y. H., Proietti, Marco
core +2 more sources
British medical journal, 2017 Objective To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg compared with warfarin among patients with atrial fibrillation who had not previously taken an oral anticoagulant.
P. Nielsen +5 more
semanticscholar +1 more source
Thromboembolic and bleeding events in ICU patients with COVID‐19: A nationwide, observational study
Acta Anaesthesiologica Scandinavica, Volume 67, Issue 1, Page 76-85, January 2023., 2023 Abstract Background Intensive care unit (ICU) patients with Coronavirus disease 2019 (COVID‐19) have an increased risk of thromboembolic complications. We describe the occurrence of thromboembolic and bleeding events in all ICU patients with COVID‐19 in Denmark during the first and second waves of the pandemic.
Lene Russell +28 more
wiley +1 more source
Scientific ReportsWarfarin remains the most prescribed oral anticoagulant of choice in atrial fibrillation (AF) patient in resource-limited settings. Despite evidence linking Time in Therapeutic Range (TTR) to patient outcomes, its use in clinical practice is not ...
Paisit Kosum +8 more
doaj +1 more source
A Case Control Study of Nutrient Intake Deficiencies in Patients Taking Warfarin
Marshall Journal of Medicine, 2015 Introduction We previously published the case of a woman taking warfarin who was found to have scurvy, a disease caused by a deficiency of vitamin C. This led us to hypothesize that patients taking warfarin who consume a diet limited in vitamin K rich
Philip Riley +5 more
doaj +1 more source
PERBANDINGAN DAYA BUNUH WARFARIN 0,105% DAN BRODIFACOUM 0,005% TERHADAP MENCIT (Mus Musculus) [PDF]
, 2005 Tikus adalah rodensia yang berperan sebagai tuan rumah perantara untuk beberapa jenis penyakit yang dikenal sebagai penyakit tular rodensia, selain dapat menimbulkan berbagai gangguan dan kerugian ekonomi.
LISTYADEWI , RATNA SARI LISTYADEWI
core
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2016 Background The introduction of non–vitamin K antagonist oral anticoagulants has been a major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in clinical trials may not translate to routine practice.
Xiaoxi Yao +6 more
semanticscholar +1 more source